Multiple sclerosis and nutrition: back to the future?

Affiliations

¹ Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Gudrunstrasse 46, Bochum, 44791, Germany.
² Department of Neurology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.

Editorial

Ralf Gold et al. Ther Adv Neurol Disord. 2020.

. 2020 Jul 31:13:1756286420936165.

doi: 10.1177/1756286420936165. eCollection 2020.

¹ Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Gudrunstrasse 46, Bochum, 44791, Germany.
² Department of Neurology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.

No abstract available

Keywords: MS; epidemiology; immunoregulation; microbiota; prevalence.

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

1. Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet 2018, 391: 1622–1636. - PubMed
1. Montalban X, Gold R, Thompson AJ, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018, 24: 96–120. - PubMed
1. Swank RL, Lerstad O, Strom A, et al. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. N Engl J Med 1952; 246: 722–728. - PubMed
1. Torkildsen O, Wergeland S, Bakke S, et al. Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 2012; 69: 1044–1051. - PubMed
1. Evers J, Welte E. Prospects for success of the evers diet in multiple sclerosis. Dtsch Med Wochenschr 1966; 30: 2352–2353. - PubMed